Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
2.21M
-
Shares change
-
-538K
-
Total reported value, excl. options
-
$48.2M
-
Value change
-
-$10.2M
-
Number of buys
-
34
-
Number of sells
-
-28
-
Price
-
$21.76
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2016
70 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2016.
IRADIMED CORP - Common Stock (IRMD) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.21M shares
of 12.7M outstanding shares and own 17.38% of the company stock.
Largest 10 shareholders include Conestoga Capital Advisors, LLC (288K shares), VANGUARD GROUP INC (224K shares), JFS WEALTH ADVISORS, LLC (190K shares), AWM Investment Company, Inc. (159K shares), BlackRock Fund Advisors (105K shares), MCKINLEY CAPITAL MANAGEMENT LLC /DELAWARE (89.6K shares), WASATCH ADVISORS INC (84K shares), Mondrian Investment Partners LTD (78.5K shares), Timpani Capital Management LLC (74.9K shares), and NORTHERN TRUST CORP (66.5K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.